These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2729933)

  • 21. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.
    De Almeida AE; De Uzeda M
    Antimicrob Agents Chemother; 1987 Apr; 31(4):617-8. PubMed ID: 3649203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
    Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R
    Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
    Betriu C; Sánchez A; Gómez M; Palau ML; Picazo JJ
    J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021.
    Fang H; Li X; Yan MK; Tong MK; Chow KH; Cheng VC; Ho PL
    Anaerobe; 2023 Aug; 82():102756. PubMed ID: 37429411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe.
    Hedberg M; Nord CE;
    Clin Microbiol Infect; 2003 Jun; 9(6):475-88. PubMed ID: 12848722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility results for the Bacteroides fragilis group: comparison of the broth microdilution and agar dilution methods.
    Hecht DW; Lederer L; Osmolski JR
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S342-5. PubMed ID: 7548593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disk diffusion susceptibility testing of the Bacteroides fragilis group.
    Horn R; Bourgault AM; Lamothe F
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1596-9. PubMed ID: 3481247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group. Danish study group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1994 Jun; 102(6):446-50. PubMed ID: 8068304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of choice of medium on the results of in vitro susceptibility testing of eight antibiotics against the Bacteroides fragilis group.
    Hecht DW; Lederer L
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S346-9. PubMed ID: 7548594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
    Teng LJ; Hsueh PR; Tsai JC; Liaw SJ; Ho SW; Luh KT
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ; Citron DM
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of the Bacteroides fragilis group in community hospitals.
    File TM; Thomson RB; Tan JS; Salstrom SJ; Jacobs GA; Johnson L; Tan L
    Diagn Microbiol Infect Dis; 1986 Nov; 5(4):317-22. PubMed ID: 3465493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.
    Schaumann R; Funke M; Janssen E; Rodloff AC
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3413-6. PubMed ID: 22430962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992.
    Tanaka-Bandoh K; Kato N; Watanabe K; Ueno K
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S352-5. PubMed ID: 7548596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
    Jamal W; Khodakhast FB; AlAzmi A; Sόki J; AlHashem G; Rotimi VO
    BMC Microbiol; 2020 Jan; 20(1):14. PubMed ID: 31941446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
    Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
    J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
    Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y
    Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
    Dornbusch K; Nord CE; Olsson-Liljeqvist B
    Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.